X-396 Capsule in Advanced NSCLC Patients With ROS1 Gene Rearrangement
Clinical trial NCT03608007 · UNKNOWN
Trial details
- NCT number
- NCT03608007
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-15
- Primary completion
- 2020-03-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.